D. M. Peereboom Et Al. , "PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES," Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference , vol.12, Florida, United States Of America, pp.53-54, 2010
Peereboom, D. M. Et Al. 2010. PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES. Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference , (Florida, United States Of America), 53-54.
Peereboom, D. M., Brewer, C. J., Suh, J. H., Chao, S. T., Parsons, M. W., Elson, P. J., ... Vogelbaum, M. A.(2010). PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES . Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference (pp.53-54). Florida, United States Of America
Peereboom, David Et Al. "PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES," Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference, Florida, United States Of America, 2010
Peereboom, David M. Et Al. "PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES." Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference , Florida, United States Of America, pp.53-54, 2010
Peereboom, D. M. Et Al. (2010) . "PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES." Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference , Florida, United States Of America, pp.53-54.
@conferencepaper{conferencepaper, author={David M. Peereboom Et Al. }, title={PHASE II TRIAL OF SUNITINIB AS MAINTENANCE THERAPY AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH 1-3 NEWLY DIAGNOSED BRAIN METASTASES}, congress name={Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference}, city={Florida}, country={United States Of America}, year={2010}, pages={53-54} }